Novel Antibody Binding to Mesothelin(MSLN), and Composition Comprising the Same

Cancer The present invention comprises a vector and a host cell, production method and the antibody of the antibody, including antibody, nucleic acid, the nucleic acid encoding the antibody specifically binding to a meso Endothelin (Mesothelin, MSLN) as an active ingredient or it relates to a pharmaceutical composition for the treatment of tumors. Antibody that specifically binds to a method endothelin according to the present invention is a high affinity to the antigen because of (affinity) and specificity (specificity) and to allow the development of antibodies that can be used effectively in the treatment or diagnosis of cancer or tumor diseases .